While only one of the pharmaceutical companies within the Fortune 500 states that they sell personal information, the company that has disclosed the sale of information is posting a “Do Not Sell My ...

Drug companies are under increasing pressure to keep prices under control. At a hearing on Capitol Hill Thursday, lawmakers from both sides of the... How Do Pharmaceutical Companies Establish Drug ...

What Happened? Shares of pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) jumped 11.6% in the morning session ...

Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing ...

In order to continue to be viable in the next decade, the pharmaceutical industry is adapting in ways that might seem surprising just a few years ago. The pressure to reduce costs coupled with the ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In today’s ever-changing market place, pharmaceutical companies are challenged to reach, ...

The pharmaceutical-sales field, often called "recession-proof," is popular because it offers excellent salary potential, great benefits, flexibility, opportunity for growth, and frequently the use of ...

Approximately 69% of pharmaceutical companies that deploy a significant number of third party behavioral advertising cookies on their websites do not utilize a cookie notice. The 31% of pharmaceutical ...

When you’re sick with the flu and facing down a week of finals, thank a pharmaceutical chemist for the medicine that brings you relief. However, this major is about much more than treating illness — ...

On this week’s JOURNAL, Bill Moyers spoke with Melody Petersen, an independent journalist who formerly covered the drug industry for the NEW YORK TIMES and is author of OUR DAILY MEDS: HOW THE ...

Much of the news people hear about pharmaceutical innovation has to do with clinical trials. So I’m writing a series of posts about these trials, which underlie regulatory approval of new medicines.